ArticleBlood cancer journal2024

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Pierre Hirsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.